User profiles for Anup Patnaik

Anup Patnaik

Centurion University
Verified email at cutm.ac.in
Cited by 5

Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors

…, JE Grob, A McRiner, MR Pancost, A Patnaik… - Bioorganic & medicinal …, 2011 - Elsevier
Herein we report the discovery of a family of novel yet simple, amino-acid derived class I
HDAC inhibitors that demonstrate isoform selectivity via access to the internal acetate release …

Identification of orally available naphthyridine protein kinase D inhibitors

…, N Pagratis, M Pancost, A Patnaik… - Journal of medicinal …, 2010 - ACS Publications
A novel 2,6-naphthyridine was identified by high throughput screen (HTS) as a dual protein
kinase C/D (PKC/PKD) inhibitor. PKD inhibition in the heart was proposed as a potential …

Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC

…, DT Parker, Y Peng, M Dobler, A Patnaik… - Journal of medicinal …, 2017 - ACS Publications
Over the past several decades, the frequency of antibacterial resistance in hospitals,
including multidrug resistance (MDR) and its association with serious infectious diseases, has …

Optical and electronic properties of some semiconductors from energy gaps

SK Tripathy, A Pattanaik - Optical Materials, 2016 - Elsevier
II-VI and III-V tetrahedral semiconductors have significant potential for novel optoelectronic
applications. In the present work, some of the optical and electronic properties of these …

2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication

…, A Honda, S Sokup, S Karur, S Britt, A Patnaik… - Bioorganic & Medicinal …, 2014 - Elsevier
Synthesis and SAR of 2-alkyloxazoles as class III phosphatidylinositol-4-kinase beta (PI4KIIIβ)
inhibitors is described. These compounds demonstrate that inhibition of PI4KIIIβ leads to …

Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO)

A Patnaik, L Axford, L Deng, E Cohick, X Ren… - Bioorganic & Medicinal …, 2020 - Elsevier
Myeloperoxidase (MPO) activity and subsequent generation of hypochlorous acid has been
associated with the killing of host-invading microorganisms (eg bacteria, viruses, and fungi). …

Intelligent Decision Support System in Healthcare using Machine Learning Models

A Patnaik - Recent Patents on Engineering, 2024 - ingentaconnect.com
Background: The use of intelligent decision support systems (IDSS) is widespread in the
healthcare industry, particularly for real-time data, client and family history datasets, and …

Discovery of a novel, highly potent and orally bioavailable pyrrolidinone indole series of irreversible Myeloperoxidase (MPO) inhibitors

…, L Deng, A Reynolds, J Mao, Q Liu, A Patnaik… - Biochemical …, 2023 - Elsevier
Myeloperoxidase (MPO) is a heme-containing peroxidase from phagocytic cells, which plays
an important role in the innate immune response. The primary anti-microbial function of …

Discovery of 1-((6-aminopyridin-3-yl) methyl)-3-(4-bromophenyl) urea as a potent, irreversible myeloperoxidase inhibitor

…, L Deng, A Reynolds, X Ren, L Axford, A Patnaik… - … of Pharmacology and …, 2018 - ASPET
Myeloperoxidase (MPO) is a leukocyte-derived redox enzyme that has been linked to oxidative
stress and damage in many inflammatory states, including cardiovascular disease. We …

Blockchain based holistic trust management protocol for ubiquitous and pervasive IoT network

A Patnaik, B Mallik, MV Krishna - Journal of Experimental & …, 2023 - Taylor & Francis
The new emerging blockchain (BC) technology integrated with the IoT ecosystem
revolutionised the IoT world. Classic BC with bitcoin method was realised as very expensive …